Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?

Clin Exp Dermatol. 2022 Aug;47(8):1585-1586. doi: 10.1111/ced.15232. Epub 2022 Jun 3.

Authors

Hans Christian Ring¹, John W Frew², Jacob P Thyssen¹, Alexander Egeberg¹, Simon F Thomsen^{1

3}

Affiliations

¹ Department of Dermato-Venereology and Wound Healing Centre, Bispebjerg Hospital, Copenhagen, Denmark.
² Department of Dermatology, Liverpool Hospital, Sydney, NSW, Australia.
³ Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.

PMID: 35437813
DOI: 10.1111/ced.15232

No abstract available

Publication types

Letter

MeSH terms

Biological Therapy
Hidradenitis Suppurativa* / drug therapy
Humans
Severity of Illness Index

Grants and funding

Lundbeck Foundation